EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study

So-Hye Jo iD, Bon-Hoon Koo iD, Kwang-Hun Lee iD, Jong-Hun Lee iD, Seung-Jae Lee iD, Young-Woo Park iD, Hyung-Mo Sung iD, Eun-Jin Cheon iD

Clinical Psychopharmacology and Neuroscience · 30.11.2026 · 24 (4) · 832-843

DOI: 10.9758/cpn.26.1422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 08.07.2026. Verfasst von So-Hye Jo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, College of Medicine, Yeungnam University, Daegu, Korea. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Otsuka Pharmaceutical Co., Ltd., Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AnxietyAripiprazoleAugmentation therapyBupropionMajor depressive disorder

Autor:innen und Institutionen

  • Department of Psychiatry, College of Medicine, Yeungnam University, Daegu, Korea.
  • Lee Gwang-hun Psychiatry Clinic, Gyeongju, Korea.
  • Department of Psychiatry, College of Medicine, Daegu Catholic University, Daegu, Korea.
  • Department of Psychiatry, Kyungpook National University School of Medicine, Daegu, Korea.
  • Park Young-woo Psychiatric Clinic, Daegu, Korea.
  • Department of Psychiatry, Soonchunhyang University Gumi Hospital, Gumi, Korea.

ORCID-Profile: So-Hye Jo, Bon-Hoon Koo, Kwang-Hun Lee, Jong-Hun Lee, Seung-Jae Lee, Young-Woo Park, Hyung-Mo Sung, Eun-Jin Cheon

Förderung

  • Otsuka Pharmaceutical Co., Ltd., Korea

Zitieren

APA

Jo, S. H., Koo, B. H., Lee, K. H., Lee, J. H., Lee, S. J., Park, Y. W., Sung, H. M., & Cheon, E. J. (2026). Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study. Clinical Psychopharmacology and Neuroscience, 24(4), 832-843. https://doi.org/10.9758/cpn.26.1422

Vancouver

Jo SH, Koo BH, Lee KH, Lee JH, Lee SJ, Park YW, et al. Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study. Clinical Psychopharmacology and Neuroscience. 2026;24(4):832-843. doi:10.9758/cpn.26.1422

BibTeX
@article{Jo2026,
  author = {Jo, So-Hye and Koo, Bon-Hoon and Lee, Kwang-Hun and Lee, Jong-Hun and Lee, Seung-Jae and Park, Young-Woo and Sung, Hyung-Mo and Cheon, Eun-Jin},
  title = {Aripiprazole versus Bupropion Augmentation in Patients with Anxious Depression Resistant to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-label, Multicenter Study},
  journal = {Clinical Psychopharmacology and Neuroscience},
  year = {2026},
  volume = {24},
  number = {4},
  pages = {832--843},
  doi = {10.9758/cpn.26.1422}
}
Kostenlos starten →